TP53 and cancer: This phenotype is consistent with whole-genome duplication (WGD) followed by limited chromosome loss, which is more frequently observed in TP53-mutant human cancers, including GBMs, than those with WT TP53 (Supplementary Fig. 2d, e)1,27,28.